New National Drug Policy in Iran leading to expanded pharmaceutical market and extended access of public to medicines

Iranian Journal of Public Health

Volumn 38, Issue SUPPL. 1, 2009, Pages 158-161

  Dinarvand, R ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Accessibility; Availability; Iran; Market trend; National drug policy; Pharmaceutical market

Indexed keywords

EID: 69749106377     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Dinarvand R (1996). Iran: An Evolving National Drug Policy. Essential Drug Monitor, 22: 9-10.
2. Nikfar S, Kebriaeezadeh A, Majdzadeh R, Abdollahi M (2005). Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran. BMC Int Health Hum Rights, 5: 5-10.
3. Cheraghali AM, Nikfar S, Behmanesh Y, Rahimi V, Hibibipour F, Tirdad R, Asadi A, Bahrami A (2004). Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. Eastern Mediterranean Health Journal 10: 406-15.
4. Basmenji K (2004). Pharmaceuticals in Iran: An overview. Archives of Iranian Medicine 7: 158-164.